Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | MOLM13; Molm13; Molm 13 |
| Species | Human |
| Cat.No | ABC-TC517S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Acute Myeloid Leukemia |
| Storage | Liquid Nitrogen |
| Product Type | Human Leukemia Cell Lines |
MOLM-13 is a human leukemia cell line derived from the peripheral blood of a patient with acute myeloid leukemia(AML), FAB M5a, at relapse. The immunotype of MOLM-13 includes CD34+, CD13−, CD14−, CD15+, CD33+, CD3−, CD4+, cy CD68+, HLA-DR−. After stimulated by INF-γ alone, or in combination with TNF-α, MOLM-13 can differentiate into macrophage-like morphology and express upregulated myelomonocyte-associated antigens. 
Internal tandem duplication of the receptor tyrosine kinase FLT3 gene is a unique feature of MOLM-13, compared to other leukemia cell lines. MOLM-13 can be cultured in RPMI1640 supplemented with 10% FBS, and the split ratio used to passage cells is 1:2 or 1:3 every 2-3 days.
Why choose MOLM-13 from AcceGen?
The cell quality of MOLM-13 from AcceGen is evaluated with various tests and analyses. Cell morphology and cell viability are examined to ensure MOLM-13 with optimal characteristics. The growth performance of MOLM-13 is also tested to gauge the stability of this cell line. Notably, MOLM-13 is conducted under culture conditions without the use of antibiotics and antimycotics, highlighting the cells’ inherent resilience. Lastly, we rigorously screened for the absence of HIV-1, HIV-2, HBV, HCV, HTLV-1, and HTLV-2, as well as microbial contaminants such as fungi, bacteria, and mycoplasma. These meticulous assessments ensure the reliability and safety of MOLM-13 for various applications.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
MOLM-13 is a useful in vitro model to investigate monocytic differentiation and leukemogenesis. For example, used in reverse transcriptase polymerase chain reaction (RT-PCR) analysis, MOLM-13 was shown to contain the mRNA of the MLL-AF9 fusion gene, which is a kind of MLL gene rearrangement and related to the leukemia development. MOLM-13 can be used to identify the genetic file of human leukemia and search for more genetic marker, such as MLL-AF9 for the diagnosis and prognosis. MLL-rearranged leukemia is hard to treat, MOLM-13 may be used in more scientific research to discover the leukemia mechanisms based on MLL fusions.
